A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
Condition(s):Acute Myeloid LeukemiaLast Updated:March 9, 2020Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:March 9, 2020Active, not recruiting
Condition(s):Hairy-cell LeukemiaLast Updated:August 30, 2016Completed
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:September 18, 2020Not yet recruiting
Condition(s):Recurrent, Refractory, or High Risk Leukemias; Matched Targeted TherapyLast Updated:April 10, 2020Suspended
Condition(s):Relapsed/Refractory Acute Myeloid Leukemia(AML)Last Updated:August 16, 2019Recruiting
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:July 30, 2020Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 12, 2019Enrolling by invitation
Condition(s):LeukemiaLast Updated:March 23, 2020Recruiting
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:April 8, 2020Completed
Condition(s):Prolymphocytic Leukemia; T-cell LeukemiaLast Updated:August 12, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.